» Articles » PMID: 16113469

Pulmonary and Systemic Oxidant/antioxidant Imbalance in Chronic Obstructive Pulmonary Disease

Overview
Specialty Pulmonary Medicine
Date 2005 Aug 23
PMID 16113469
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

An imbalance between oxidants and antioxidants is considered to play a role in the pathogenesis of chronic obstructive pulmonary disease (COPD). There is considerable evidence that an increased oxidative burden occurs in the lungs of patients with this disorder, and this may be involved in many of the pathogenic processes, such as direct injury to lung cells, mucus hypersecretion, inactivation of antiproteases, and enhancing lung inflammation through activation of redox-sensitive transcription factors. COPD is now recognized to have multiple systemic consequences, such as weight loss and skeletal muscle dysfunction. Moreover, it is appreciated that oxidative stress extends beyond the lung and may, through similar oxidative stress mechanisms as those in the lung, contribute to several of the systemic manifestations in COPD.

Citing Articles

Understanding the impact of ER stress on lung physiology.

Fu Z, Wang W, Gao Y Front Cell Dev Biol. 2025; 12:1466997.

PMID: 39744015 PMC: 11688383. DOI: 10.3389/fcell.2024.1466997.


NADPH Oxidase 3: Beyond the Inner Ear.

Herb M Antioxidants (Basel). 2024; 13(2).

PMID: 38397817 PMC: 10886416. DOI: 10.3390/antiox13020219.


Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.

De Rubis G, Paudel K, Corrie L, Mehndiratta S, Patel V, Kumbhar P Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):2793-2833.

PMID: 37991539 DOI: 10.1007/s00210-023-02830-w.


infection-A risk factor for lipid peroxidation and superoxide dismutase over-activity: A cross-sectional study among patients with dyspepsia in Cameroon.

Faujo Nintewoue G, Tali Nguefak L, Ngatcha G, Tagni S, Talla P, Menzy Moungo-Ndjole C JGH Open. 2023; 7(9):618-628.

PMID: 37744703 PMC: 10517442. DOI: 10.1002/jgh3.12958.


Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.

Douglas D, Keating L, Strykowski R, Lee C, Garcia N, Selvan K Am J Physiol Lung Cell Mol Physiol. 2023; 325(2):L233-L243.

PMID: 37366539 PMC: 10396279. DOI: 10.1152/ajplung.00083.2023.